| P50 | author | Claudiu T Supuran | Q28211545 |
| P2093 | author name string | Mikhail Krasavin | |
| | Aleksandrs Pustenko | |
| | Alessio Nocentini | |
| | Anastasija Balašova | |
| | Raivis Žalubovskis | |
| P2860 | cites work | Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste | Q27647390 |
| | Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms | Q27650001 |
| | Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors | Q27653712 |
| | Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins | Q27658153 |
| | The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors | Q27658742 |
| | Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases | Q27683603 |
| | A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects | Q27698485 |
| | Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the η-carbonic anhydrases | Q27973368 |
| | Carbonic anhydrases: novel therapeutic applications for inhibitors and activators | Q28263238 |
| | The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C | Q28646334 |
| | Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs | Q33236577 |
| | Interfering with pH regulation in tumours as a therapeutic strategy | Q37933052 |
| | (In)organic anions as carbonic anhydrase inhibitors | Q37970856 |
| | Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? | Q38011235 |
| | Anti-infective carbonic anhydrase inhibitors: a patent and literature review | Q38089125 |
| | An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? | Q38207158 |
| | Bacterial, fungal and protozoan carbonic anhydrases as drug targets. | Q38559435 |
| | How many carbonic anhydrase inhibition mechanisms exist? | Q38653464 |
| | Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium | Q38829966 |
| | Carbonic anhydrase inhibition and the management of neuropathic pain | Q38841249 |
| | 6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells | Q38887024 |
| | Structure and function of carbonic anhydrases | Q38894649 |
| | Advances in structure-based drug discovery of carbonic anhydrase inhibitors | Q38991378 |
| | Carbonic Anhydrase Inhibition and the Management of Hypoxic Tumors | Q41666673 |
| | Transition Metal Ion Complexes of Schiff-bases. Synthesis, Characterization and Antibacterial Properties | Q41852163 |
| | Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. | Q42723906 |
| | 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range | Q42822569 |
| | Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. | Q42950788 |
| | Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II. | Q43004616 |
| | In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds. | Q44523008 |
| | Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols. | Q46115394 |
| | Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? | Q47692161 |
| | Synthesis, biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors. | Q47738911 |
| | 3H-1,2-benzoxathiepine 2,2-dioxides: a new class of isoform-selective carbonic anhydrase inhibitors. | Q48030765 |
| | Nanoemulsions of sulfonamide carbonic anhydrase inhibitors strongly inhibit the growth of Trypanosoma cruzi | Q48205296 |
| | Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis | Q48363805 |
| | 7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors. | Q50906282 |
| | Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors. | Q52145888 |
| | Carbonic Anhydrases and Metabolism. | Q52645009 |
| | Dioxygen, an unexpected carbonic anhydrase ligand. | Q55526704 |
| | Carbonic anhydrase inhibition with a series of novel benzenesulfonamide-triazole conjugates | Q57023564 |
| | Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors | Q57279715 |
| | Carbonic Anhydrase Inhibitors: Perfluoroalkyl/Aryl-Substituted Derivatives of Aromatic/Heterocyclic Sulfonamides as Topical Intraocular Pressure-Lowering Agents with Prolonged Duration of Action | Q58863330 |
| | Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one | Q60888687 |
| | Mono- and di-thiocarbamate inhibition studies of the δ-carbonic anhydrase TweCAδ from the marine diatom Thalassiosira weissflogii. | Q64897539 |
| | Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails. | Q64949231 |
| | 7-Aryl-triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrase IX and XII | Q86934627 |
| | Deciphering the Mechanism of Human Carbonic Anhydrases Inhibition with Sulfocoumarins: Computational and Experimental Studies | Q88231025 |
| | Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis | Q88626204 |
| | Biomedical applications of prokaryotic carbonic anhydrases | Q89420700 |
| | Crystal structure and chemical inhibition of essential schistosome host-interactive virulence factor carbonic anhydrase SmCA | Q90054165 |
| | Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones | Q90431648 |
| | Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019 | Q90609438 |
| | Applications of carbonic anhydrases inhibitors in renal and central nervous system diseases | Q91269702 |
| | Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas | Q91453043 |
| | Steroids interfere with human carbonic anhydrase activity by using alternative binding mechanisms | Q91476816 |
| | A new widespread subclass of carbonic anhydrase in marine phytoplankton | Q91525219 |
| | Aryl derivatives of 3H-1,2-benzoxathiepine 2,2-dioxide as carbonic anhydrase inhibitors | Q91605843 |
| | Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery | Q92765532 |
| | Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors | Q93065311 |
| | 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles | Q93104584 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 650-656 | |
| P577 | publication date | 2020-12-01 | |
| P1433 | published in | Journal of Enzyme Inhibition and Medicinal Chemistry | Q15708877 |
| P1476 | title | 7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors | |
| P478 | volume | 35 | |